Ligand validation:5NJ1

A6R: arsenoplatin-1

A6R is a Ligand Of Interest in 5NJ1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NJ1_A6R_A_208	96%	26%	0.089	0.996	1.35	1.62	1	-	0	0	100%	0.6
6ZS8_A6R_AAA_406	99%	12%	0.062	0.997	0.64	3.33	-	2	0	0	100%	0.8
5NJ7_A6R_A_202	93%	10%	0.095	0.99	0.7	3.54	-	2	0	0	100%	0.75
7BD7_A6R_A_223	58%	21%	0.189	0.968	1.66	1.67	-	2	1	0	100%	0.4
8C63_A6R_B_101	7%	14%	0.378	0.841	0.92	2.9	-	2	1	0	100%	0.2

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.